These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 29029807

  • 1. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X, Xu Y, Scott DE, Murata H, Struble EB.
    Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
    [Abstract] [Full Text] [Related]

  • 2. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM, Huber TM, Kühne M, Lieby P, Snydman DR, Vensak JL, Berger M.
    Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
    [Abstract] [Full Text] [Related]

  • 3. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J, Peppard J, Emanuel D.
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [Abstract] [Full Text] [Related]

  • 4. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M, Herbener P, Schüttrumpf J.
    Ann Transplant; 2016 Sep 06; 21():558-64. PubMed ID: 27595792
    [Abstract] [Full Text] [Related]

  • 5. RT-qPCR-based microneutralization assay for human cytomegalovirus using fibroblasts and epithelial cells.
    Wang X, Peden K, Murata H.
    Vaccine; 2015 Dec 16; 33(51):7254-7261. PubMed ID: 26552003
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB, Saemann MD, Gajek H, Farcet MR, Kreil TR.
    Transplantation; 2011 Aug 15; 92(3):267-70. PubMed ID: 21659947
    [Abstract] [Full Text] [Related]

  • 7. IgG subclass antibodies to human cytomegalovirus (CMV) in normal human plasma samples and immune globulins and their neutralizing activities.
    Gupta CK, Leszczynski J, Gupta RK, Siber GR.
    Biologicals; 1996 Jun 15; 24(2):117-24. PubMed ID: 8889058
    [Abstract] [Full Text] [Related]

  • 8. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
    Schampera MS, Schweinzer K, Abele H, Kagan KO, Klein R, Rettig I, Jahn G, Hamprecht K.
    J Clin Virol; 2017 May 15; 90():40-45. PubMed ID: 28342316
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of CMV ELISA antibody: titer and neutralizing activity in intramuscular immune globulin of placental origin.
    Gibert R, el Habib R, Allard JP, Defayolle M, Aymard M.
    Transplant Proc; 1987 Oct 15; 19(5):4083-6. PubMed ID: 2823436
    [Abstract] [Full Text] [Related]

  • 10. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
    Cui X, Freed DC, Wang D, Qiu P, Li F, Fu TM, Kauvar LM, McVoy MA.
    J Virol; 2017 Jul 01; 91(13):. PubMed ID: 28381568
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.
    Cui X, Adler SP, Schleiss MR, Arav-Boger R, Demmler Harrison GJ, McVoy MA.
    Clin Vaccine Immunol; 2017 Jun 01; 24(6):. PubMed ID: 28404573
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neutralizing activity of saliva against cytomegalovirus.
    Saccoccio FM, Gallagher MK, Adler SP, McVoy MA.
    Clin Vaccine Immunol; 2011 Sep 01; 18(9):1536-42. PubMed ID: 21795465
    [Abstract] [Full Text] [Related]

  • 17. A two-step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus.
    Falk JJ, Winkelmann M, Schrezenmeier H, Stöhr D, Sinzger C, Lotfi R.
    Transfusion; 2017 Feb 01; 57(2):412-422. PubMed ID: 27861998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.